“…Its use has been documented for more than four decades, but its use in the treatment of heart failure is incipient. Numerous small clinical studies of patients with stable chronic angina pectoris have shown improved cardiac perfusion imaging (2,(8)(9)(10)(11)(12)(13), reduction of angina class (2,9,10,12,13), increases in exercise tolerance (2,(8)(9)(10)(11), decreased use of nitroglycerine (10,12,13) and increased time to ST segment depression on stress testing with the use of EECP (2,8). Some of these studies have shown a sustained improvement for as long as five years after treatment (13).…”